Tags:Drug
Biopharmaceutical company focused on drugs to treat CNS disorders by targeting neuronal nicotinic receptors
Member count: 11-50
Total raised: $10M
Founded date: 1997

Investors 1

DateNameWebsite
07.08.2021New Enterp...nea.com

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
10.06.2011-$10M-medcitynew...

Mentions in press and media 41

DateTitleDescriptionCategoryAuthorSource
04.06.2012Targacept ...Targacept in April announced a...--medcitynew...
03.05.2012Targacept’...Winston-Salem, North Carolina-...--medcitynew...
25.04.2012Targacept ...The restructuring and layoffs ...--medcitynew...
11.04.2012Asthma com...In the asthma study, TC-6987 w...--medcitynew...
27.03.2012Asthma dru...TC-6987 was studied in two sep...--medcitynew...
20.03.2012Targacept,...Targacept had planned five pha...--medcitynew...
21.02.2012Depression...“While many eyes externally ha...--medcitynew...
07.02.2012Tale of 2 ...Since AstraZeneca’s first rest...--medcitynew...
05.01.2012AstraZenec...The Targacept/AstraZeneca coll...--medcitynew...
09.12.2011CeNeRx, ex...The Cary, North Carolina compa...--medcitynew...
Show more